The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP)

The Product Quality Research Institute (PQRI) is a non-profit consortium of organizations working together to generate and share timely, relevant, and impactful information that advances drug product quality and development. The collaborative activities of PQRI participants have, in the case of orally inhaled and nasal drug products (OINDPs), resulted in comprehensive and widely-accepted recommendations for leachables assessments to help ensure patient safety with respect to this class of packaged drug products. These recommendations, which include scientifically justified safety thresholds for leachables, represent a significant milestone towards establishing standardized approaches for safety qualification of leachables in OINDP. To build on the success of the OINDP effort, PQRI's Parenteral and Ophthalmic Drug Products (PODP) Leachables and Extractables Working Group was formed to extrapolate the OINDP threshold concepts and best practice recommendations to other dosage forms with high concern for interaction with packaging/delivery systems. This article considers the general aspects of leachables and their safety assessment, introduces the PODP Work Plan and initial study Protocol, discusses the laboratory studies being conducted by the PODP Chemistry Team, outlines the strategy being developed by the PODP Toxicology Team for the safety qualification of PODP leachables, and considers the issues associated with application of the safety thresholds, particularly with respect to large-volume parenterals. Lastly, the unique leachables issues associated with biologics are described. LAY ABSTRACT: The Product Quality Research Institute (PQRI) is a non-profit consortium involving industry organizations, academia, and regulatory agencies that together provide recommendations in support of regulatory guidance to advance drug product quality. The collaborative activities of the PQRI Orally Inhaled and Nasal Drug Products Leachables and Extractables Working Group resulted in a systematic and science-based approach to identify and qualify leachables, including the concept of safety thresholds. Concepts from this widely accepted approach, formally publicized in 2006, are being extrapolated to parenteral and ophthalmic drug products. This article provides an overview of extractables and leachables in drug products and biologics and discusses the PQRI Work Plan and Protocols developed by the PQRI Parenteral and Ophthalmic Drug Products Leachables and Extractables Working Group.

[1]  G. Ulsaker,et al.  Identification of caprolactam as a potential contaminant in parenteral solutions stored in overwrapped PVC bags. , 1992, Journal of pharmaceutical and biomedical analysis.

[2]  R. Nation,et al.  Leaching of 2-(2-hydroxyethylmercapto) benzothiazole into contents of disposable syringes. , 1981, Journal of pharmaceutical sciences.

[3]  J. Reepmeyer,et al.  Contamination of injectable solutions with 2-mercaptobenzothiazole leached from rubber closures. , 1983, Journal of pharmaceutical sciences.

[4]  M. Satoh,et al.  Induction of Hypergammaglobulinemia and Macrophage Activation by Silicone Gels and Oils in Female A.SW Mice , 2000, Clinical Diagnostic Laboratory Immunology.

[5]  O. Poulsen,et al.  Adjuvant and immuno-suppressive effect of six monophthalates in a subcutaneous injection model with BALB/c mice. , 2001, Toxicology.

[6]  M. Schladweiler,et al.  Soluble iron modulates iron oxide particle-induced inflammatory responses via prostaglandin E2 synthesis: In vitro and in vivo studies , 2009, Particle and Fibre Toxicology.

[7]  J. Kreuter,et al.  Interaction of rubber closures with powders for parenteral administration. , 1990, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[8]  S. Ohno,et al.  Effects of Various Chemicals Including Endocrine Disruptors and Analogs on the Secretion of Th1 and Th2 Cytokines from Anti CD3-Stimulated Mouse Spleen Cells , 2003 .

[9]  J. Naim,et al.  The effect of molecular weight and gel preparation on humoral adjuvancy of silicone oils and silicone gels. , 1995, Immunological investigations.

[10]  S. Larsen,et al.  The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated through a PPARalpha-independent mechanism. , 2007, Toxicology letters.

[11]  I. Macdougall,et al.  Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here? , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  K. Komvopoulos,et al.  Chemical and biological characteristics of low-temperature plasma treated ultra-high molecular weight polyethylene for biomedical applications , 2001, Journal of materials science. Materials in medicine.

[13]  R. P. Snell.  Solid-phase extraction and liquid chromatographic determination of monophthalates and phthalide extracted from solution administration sets. , 1993, Journal of AOAC International.

[14]  G. Ulsaker,et al.  Determination of cyclohexanone in intravenous solutions stored in PVC bags by gas chromatography. , 1977, The Analyst.

[15]  A G Renwick,et al.  Structure-based thresholds of toxicological concern--guidance for application to substances present at low levels in the diet. , 2005, Toxicology and applied pharmacology.

[16]  W. Driver.  Plastics chemistry and technology , 1979 .

[17]  D. Jenke.  Compatibility of Pharmaceutical Products and Contact Materials , 2009 .

[18]  D. Jenke.  A General Strategy for the Chemical Aspects of the Safety Assessment of Extractables and Leachables in Pharmaceutical Drug Products: The Chemical Assessment Triad , 2012, PDA Journal of Pharmaceutical Science and Technology.

[19]  R. Hagemann,et al.  The adjuvant activity of diesel exhaust particles and carbon black on systemic IgE production to ovalbumin in mice after intranasal instillation. , 1997, Toxicology.

[20]  P. Thygesen,et al.  Di-(2-ethylhexyl) phthalate possesses an adjuvant effect in a subcutaneous injection model with BALB/c mice. , 2001, Toxicology letters.

[21]  R A Ford,et al.  Correlation of structural class with no-observed-effect levels: a proposal for establishing a threshold of concern. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[22]  R A Ford,et al.  Estimation of toxic hazard--a decision tree approach. , 1978, Food and cosmetics toxicology.

[23]  Leo M.L. Nollet,et al.  Handbook of food analysis , 1996 .

[24]  Y. Haishima,et al.  Elution of bisphenol-A from hemodialyzers consisting of polycarbonate and polysulfone resins. , 2001, Journal of biomedical materials research.

[25]  T. Høy,et al.  Committee for Medicinal Products for Veterinary Use CVMP assessment report for type II variation for Panacur , 2004 .

[26]  R. P. Snell.  Capillary GC analysis of compounds leached into parenteral solutions packaged in plastic bags. , 1989, Journal of chromatographic science.

[27]  G. Heavner,et al.  Recognition and identification of UV-absorbing leachables in EPREX pre-filled syringes: an unexpected occurrence at a formulation-component interface. , 2007, PDA journal of pharmaceutical science and technology.

[28]  D. Jenke.  Extractable substances from plastic materials used in solution contact applications: an updated review. , 2006, PDA journal of pharmaceutical science and technology.

[29]  E. Marth,et al.  The effect of heavy metals on the immune system at low concentrations. , 2001, International Journal of Occupational Medicine and Environmental Health.

[30]  R. L. Mueller,et al.  Reducing the Risk of Contamination of Sterile Parenteral Products via Ready-to-Use Closure Components , 2010, AAPS PharmSciTech.

[31]  J. W. Danielson.  Toxicity potential of compounds found in parenteral solutions with rubber stoppers. , 1992, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[32]  J. Samet,et al.  Food and Drug Administration , 2007, BMJ : British Medical Journal.

[33]  R. Seymour,et al.  Advances in polyolefins : the world's most widely used polymers , 1987 .

[34]  R. Kroes.  Structure-Based Thresholds of Toxicological Concern (TTC): Guidance for Application to Substances Present at Low Levels in the Diet , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[35]  M. Løvik,et al.  Diesel exhaust particles and carbon black have adjuvant activity on the local lymph node response and systemic IgE production to ovalbumin. , 1997, Toxicology.

[36]  C. Hansson,et al.  Chemical changes in rubber allergens during vulcanization , 2007, Contact dermatitis.

[37]  I. Macdougall,et al.  Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here? , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  S. D. Pearson,et al.  Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components. , 1993, American journal of hospital pharmacy.

[39]  D. Jenke,et al.  Accumulation of extractables in buffer solutions from a polyolefin plastic container. , 2005, International journal of pharmaceutics.

[40]  V. Katta,et al.  Leachables from Saline-Containing IV Bags Can Alter Therapeutic Protein Properties , 2010, Pharmaceutical Research.

[41]  A. Wu,et al.  Plasticizers, antioxidants, and other contaminants found in air delivered by PVC tubing used in respiratory therapy. , 2003, Biomedical chromatography : BMC.

[42]  I. Markovic.  Evaluation of safety and quality impact of extractable and leachable substances in therapeutic biologic protein products: a risk-based perspective , 2007, Expert opinion on drug safety.

[43]  Richard Vivilecchia,et al.  Strategy for identification of leachables in packaged pharmaceutical liquid formulations. , 2008, Journal of pharmaceutical and biomedical analysis.

[44]  Mary Jo Garber,et al.  Accumulation of organic compounds leached from plastic materials used in biopharmaceutical process containers. , 2007, PDA journal of pharmaceutical science and technology.

[45]  D. Jenke.  Extractable/leachable substances from plastic materials used as pharmaceutical product containers/devices. , 2002, PDA journal of pharmaceutical science and technology.